BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Fate Therapeutics To Webcast Conference Call Reporting Second Quarter 2015 Financial Results On August 5, 2015

  July 30, 2015

   · 

  1 min read
• Business

  Inovio Pharmaceuticals To Host Second Quarter 2015 Financial Results Conference Call August 10, 2015

  July 30, 2015

   · 

  4 min read
• Business

  NeuroDerm To Host Second Quarter 2015 Financial Results Conference Call On August 6, 2015

  July 30, 2015

   · 

  2 min read
• Drug Development

  Galapagos’ Selective JAK1 Inhibitor Filgotinib Meets Key Efficacy Endpoints, Shows ACR70 Responses Up To 39%, And Maintains Safety Profile After 24 Weeks Of Treatment In DARWIN 1 Phase 2B Study

  July 30, 2015

   · 

  7 min read
• Drug Development

  Suzhou Connect Reports Positive Results For Trial Of Autoimmune Drug

  July 30, 2015

   · 

  1 min read
• Business

  Pharming Group Reports On Financial Results First Half Year 2015

  July 30, 2015

   · 

  4 min read
• Business

  Smith & Nephew Inc. Second Quarter Trading And First Half 2015 Results

  July 30, 2015

   · 

  2 min read
• Drug Development

  Ascendis Pharma A/S To Report Top-Line Results From A Phase 2 Pediatric Study Of Once-Weekly Transcon Growth Hormone And Host Conference Call On Thursday, July 30, 2015 At 9:00 A.M. Eastern Time

  July 30, 2015

   · 

  2 min read
• Business

  RXi Pharmaceuticals To Webcast Second Quarter 2015 Financial Results On Wednesday, August 12, 2015

  July 30, 2015

   · 

  4 min read
• AEterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development

  July 30, 2015

   · 

  3 min read